Global Swedish Porphyria Therapeutics Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias. According to this study, over the next five years the... more

Global Swedish Porphyria Treatment Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias. According to this study, over the next five years the... more

Global Swedish Porphyria Drugs Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias. According to this study, over the next five years the... more

Global Acute Intermittent Porphyria Therapeutics Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It... more

Global Acute Intermittent Porphyria Treatment Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It... more

Global Acute Intermittent Porphyria Drugs Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It... more

Global Swedish Porphyria Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias. According to this study, over the next five years the... more

Global Panhematin Drugs Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Panhematin is an iron-containing porphyrin with chlorine that can be formed from a haem group, such as haem b found in the haemoglobin of human blood. According to this study, over the next five years the Panhematin Drugs market will register a xx% CAGR in terms... more

Global Hemin Drugs Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Hemin is an iron-containing porphyrin with chlorine that can be formed from a haem group, such as haem b found in the haemoglobin of human blood. According to this study, over the next five years the Hemin Drugs market will register a xx% CAGR in terms of revenue,... more

Global Panhematin Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Panhematin is an iron-containing porphyrin with chlorine that can be formed from a haem group, such as haem b found in the haemoglobin of human blood. According to this study, over the next five years the Panhematin market will register a xx% CAGR in terms of... more

Global Hemin Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Hemin is an iron-containing porphyrin with chlorine that can be formed from a haem group, such as haem b found in the haemoglobin of human blood. According to this study, over the next five years the Hemin market will register a xx% CAGR in terms of revenue, the... more

Global Acromegaly Drugs Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Acromegaly is a disorder that results from excess growth hormone (GH) after the growth plates have closed. In this report, we study the drugs for Acromegaly. According to this study, over the next five years the Acromegaly Drugs market will register a xx% CAGR... more

Global Acromegaly Therapeutics Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Acromegaly is a disorder that results from excess growth hormone (GH) after the growth plates have closed. In this report, we study the drugs for Acromegaly. According to this study, over the next five years the Acromegaly Therapeutics market will register a xx%... more

Global Somavert Drugs Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Pegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. According to this study, over the next five years the Somavert Drugs market will register a xx% CAGR in terms of revenue, the global market size will... more

Global Pegvisomant Drugs Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Pegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. According to this study, over the next five years the Pegvisomant Drugs market will register a xx% CAGR in terms of revenue, the global market size will... more